Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 18Terminated 10Recruiting 7Withdrawn 3Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Colorectal Neoplasms 43Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Colonic Neoplasms 12Neoplasm Metastasis 9Head and Neck Neoplasms 8Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Colorectal Cancer Metastatic 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Squamous Cell 2mCRC 1Stomach Neoplasms 1Skin Neoplasms 1Recurrence 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Liver Metastasis Colon Cancer 1Incurable Colorectal Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1

Interventions

Cisplatin 10Paclitaxel 9Radiotherapy 5Fluorouracil 5Radiotherapy, Intensity-Modulated 4Docetaxel 4Carboplatin 4advexin 2Therapeutics 2Surveys and Questionnaires 2Oxaliplatin 2Leucovorin 2Drug Therapy 2Cetuximab 2Afatinib 2penpulimab 1pembrolizumab 1olaparib 1niraparib 1nimotuzumab 1nedaplatin 1durvalumab 1daromun 1camrelizumab 1calcipotriene 1atezolizumab 1afamelanotide 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Squamous Cell × Cetuximab × Clear all
NCT03051906 2017-11-22

DUCRO-HN

Azienda Ospedaliero-Universitaria Careggi

Phase 1/2 Unknown
69 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01760811 2013-01-04

CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

Rabin Medical Center

Phase 1/2 Unknown
25 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡